Freed Investment Group - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 23 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Freed Investment Group ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$107,000
+311.5%
52,900
+262.3%
0.08%
+256.5%
Q1 2021$26,000
-10.3%
14,600
-48.8%
0.02%
-14.8%
Q4 2020$29,00028,5000.03%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Inspire Advisors, LLC 188,796$291,0000.08%
Horst & Graben Wealth Management LLC 75,722$117,0000.03%
Alpine Global Management, LLC 83,475$129,0000.02%
Miller Investment Management, LP 50,000$77,0000.01%
SABBY MANAGEMENT, LLC 30,863$48,0000.01%
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC 49,075$76,0000.00%
Alberta Investment Management Corp 172,185$265,0000.00%
Syverson Strege & Co 2,145$3,0000.00%
HighTower Advisors, LLC 170,623$263,0000.00%
HRT FINANCIAL LP 90,871$139,0000.00%
View complete list of CITIUS PHARMACEUTICALS INC shareholders